Synthesis and Functional Characterization of Tridegin and Its Analogues: Inhibitors and Substrates of Factor XIIIa

被引:25
作者
Boehm, Miriam [1 ]
Kuehl, Toni [1 ,2 ]
Hardes, Kornelia [3 ]
Coch, Richard [2 ]
Arkona, Christoph [4 ]
Schlott, Bernhard [5 ]
Steinmetzer, Torsten [3 ]
Imhof, Diana [1 ]
机构
[1] Univ Bonn, Inst Pharm, D-53119 Bonn, Germany
[2] Univ Jena, Dept Biochem, Inst Biochem & Biophys, D-07745 Jena, Germany
[3] Univ Marburg, Dept Pharm, Inst Pharmaceut Chem, D-35032 Marburg, Germany
[4] Univ Leipzig, Inst Pharm, D-04103 Leipzig, Germany
[5] Fritz Lipmann Inst, Leibniz Inst Age Res, D-97745 Jena, Germany
关键词
factor XIII; inhibitors; ionic liquids; peptides; transferases; NATIVE CHEMICAL LIGATION; COAGULATION FACTOR-XIII; ACTIVATED FACTOR-XIII; IONIC LIQUIDS; THROMBIN; TRANSGLUTAMINASE; PEPTIDES; ENZYME; FIBRINOGEN; PROTEINS;
D O I
10.1002/cmdc.201100405
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tridegin, a 66-mer peptide isolated from the leech Haementeria ghilianii, is a potent inhibitor of the coagulation factor XIIIa. This paper describes the chemical synthesis of tridegin by two different strategiessolid-phase assembly and native chemical ligationboth followed by oxidation in solution phase. Tridegin and truncated analogues were examined for their activity and revealed a particular importance of the C-terminal region of the parent peptide. Based on these studies a minimal sequence required for factor XIIIa inhibition could be identified. Our data revealed that the glutamine residue at position 52 (Q52) of tridegin most likely binds to the active site of factor XIIIa and was therefore suggested to react with the enzyme. The function of the N-terminal region is also discussed, as the isolated C-terminal segment of tridegin lost its inhibitory activity rapidly in the presence of factor XIIIa, whereas this was not the case for the full-length inhibitor.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
[1]   Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis [J].
AbdAlla, S ;
Lother, H ;
Langer, A ;
el Faramawy, Y ;
Quitterer, U .
CELL, 2004, 119 (03) :343-354
[2]  
Arkona C., 2009, 12 MIPTEC C OCT 13 1
[3]  
Atkinson J. G., 1988, Eur. Pat. Appl., Patent No. [EP 0294016, 0294016]
[4]  
Baldwin J. J., 1991, US Pat, Patent No. [US 5030644, 5030644]
[5]  
Bardos H, 1996, BLOOD COAGUL FIBRIN, V7, P536
[6]   Characterizing the specificity of activated factor XIII for glutamine-containing substrate peptides [J].
Cleary, David B. ;
Maurer, Muriel C. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2006, 1764 (07) :1207-1217
[7]   SYNTHESIS OF PROTEINS BY NATIVE CHEMICAL LIGATION [J].
DAWSON, PE ;
MUIR, TW ;
CLARKLEWIS, I ;
KENT, SBH .
SCIENCE, 1994, 266 (5186) :776-779
[8]  
Escher SE, 2001, LETT PEPT SCI, V8, P349
[9]   Gene expression in the salivary complexes from Haementeria depressa leech through the generation of expressed sequence tags [J].
Faria, F ;
Junqueira-de-Azevedo, ID ;
Ho, PL ;
Sampaio, MU ;
Chudzinski-Tavassi, AM .
GENE, 2005, 349 :173-185
[10]  
FICKENSCHER K, 1991, THROMB HAEMOSTASIS, V65, P535